Association study of COX-2 (PTGS2) -765 G/C promoter polymorphism by pyrosequencing in Sicilian patients with Alzheimer's disease

Archives of Medical Science

Volumn 10, Issue 6, 2014, Pages 1235-1238

  Michele, Salemi ^a   Salluzzo, Maria Grazia ^a   Calogero, Aldo E ^b   Rafaele, Ferri ^a   Bosco, Paolo ^a  

^a OASI RESEARCH INSTITUTE IRCCS   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Alzheimer disease; COX 2 gene; Polymorphism; Pyrosequencing

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; CYCLOOXYGENASE 2 GENE; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; ITALIAN (CITIZEN); MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; PYROSEQUENCING;

EID: 84920035912     PISSN: 17341922     EISSN: 18969151     Source Type: Journal    
DOI: 10.5114/aoms.2014.47832     Document Type: Article

References (18)

1. WHO, Dementia: a public health priority. World Health Organization 2012.
2. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med 2010; 362: 329-44.
3. Dubois RN, Abramson SB, Croford L, et al. Cyclooxygen-ase in biology and disease. FASEB J 1998; 12: 1063-73.
4. Qin Y, Tian YP. Protective efects of total glucosides of paeony and the underlying mechanisms in carbon tet-rachloride-induced experimental liver injury. Arch Med Sci 2011; 7: 604-12.
5. Saunders AJ, Bertram L, Mullin K, et al. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet 2003; 12: 23-32.
6. Hoozemans JJ, Rozemuller AJ, Janssen I, De Groot CJ, Veerhuis R, Eikelenboom P. Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain. Acta Neuropathol 2001; 101: 2-8.
7. Abdullah L, Ait-Ghezala G, Crawford F, et al. The cycloo-xygenase 2-765C promoter allele is a protective factor for Alzheimer's disease. Neurosci Lett 2005; 395: 240-3.
8. Tang W, He M, Yang B, Wei K, Yin M, Zhang L. Association study of polymorphisms in the cyclooxygenase-2 gene and Alzheimer's disease risk in Chinese. Neurol Sci 2013; 34: 695-9.
9. Ahmadian A, Ehn M, Hober S. Pyrosequencing: history, biochemistry and future. Clin Chim Acta 2006; 363: 83-94.
10. Gharizadeh B, Herman ZS, Eason RG, Jejelowo O, Pour-mand N. Large-scale pyrosequencing of synthetic DNA: a comparison with results from Sanger dideoxy sequencing. Electrophoresis 2006; 27: 3042-7.
11. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 263-9.
12. Skarke C, Schuss P, Kirchhof A, et al. Pyrosequencing of polymorphisms in the COX-2 gene (PTGS2) with reported clinical relevance. Pharmacogenomics 2007; 8: 1643-60.
13. Cohen J. Statistical power analysis for the behavioral sciences (2nd ed.). Lawrence Erlbaum, New Jersey 1988.
14. Minghetti L, Pocchiari M. Cyclooxygenase-2, prostaglan-din E2, and microglial activation in prion diseases. Int Rev Neurobiol 2007; 82: 265-75.
15. Levy-Lahad E, Wijsman EM, Nemens E, et al. A familial Alzheimer's disease locus on chromosome 1. Science 1995; 269: 970-3.
16. Listì F, Caruso C, Lio D, et al. Role of cyclooxygenase-2 and 5-lipoxygenase polymorphisms in Alzheimer's disease in a population from northern Italy: implication for pharmacogenomics. J Alzheimers Dis 2010; 19: 551-7.
17. Fehér A, Juhász A, Rimanóczy A, et al. Association study of interferon-gamma, cytosolic phospholipase A2, and cyclooxygenase-2 gene polymorphismsin Alzheimer disease. Am J Geriatr Psychiatry 2010; 18: 983-7.
18. Tang W, He M, Yang B, et al. Association study of polymorphisms in the cyclooxygenase-2 gene and Alzheimer's disease risk in Chinese. Neurol Sci 2013; 34: 695-9.